Skip to main content
DONGSUNG PHARMACEUTICAL CO.,LTD logo

DONGSUNG PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 002210 ISIN · KR7002210003 KO Manufacturing
Open in API
Filings indexed 367 across all filing types
Latest filing 2026-04-03 Capital/Financing Update
Country KR South Korea
Listing KO 002210

About DONGSUNG PHARMACEUTICAL CO.,LTD

http://dongsung-pharm.com/user-english/

Dongsung Pharmaceutical Co., Ltd., established in 1957, develops, manufactures, and markets a diverse range of products across pharmaceuticals, cosmetics, and hair care. The company's pharmaceutical division produces over-the-counter (OTC) drugs and is expanding into health functional foods. Its portfolio also includes a variety of cosmetic products and is particularly known for its hair dyes. Dongsung Pharmaceutical focuses on developing nature-friendly products and is engaged in advanced research, including photodynamic therapy (PDT) for potential cancer treatments.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a Korean 주요사항보고서 (“Report of Major Matters”) detailing the terms and a correction (“정정신고”) of the decision to issue convertible bonds (전환사채권). It provides full financing details (principal amount, interest, maturity, conversion terms, put‐option, etc.), which constitutes a corporate financing activity. This is not an AGM or earnings release, but rather a detailed issuance of debt with convertible features – a capital/financing update. Therefore, the correct classification is Capital/Financing Update (CAP).
2026-04-03 Korean
[기재정정]주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a Korean "주요사항보고서(감자 결정)" – a material event report announcing and correcting details of a capital reduction (감자 결정). This falls squarely under "Share Issue/Capital Change" (new share issues, stock splits, capital changes). Therefore, the appropriate classification is SHA.
2026-04-02 Korean
최대주주등소유주식변동신고서(최대주주변경시)
Major Shareholding Notification Classification · 1% confidence The document is a ‘최대주주등소유주식변동신고서’ (Notice of Change in Major Shareholder Ownership) detailing shareholding changes by the company’s largest shareholders, including pre- and post-change share counts and percentages. This matches the definition of a Major Shareholding Notification (code MRQ).
2026-04-01 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a Korean Major Issues Report (“주요사항보고서”) disclosing the decision to issue convertible bonds, detailing terms, conversion price, interest, maturity and use of proceeds. It is not an annual or interim report, earnings release, or proxy statement. Instead, it is a financing announcement related to capital structure (issuance of convertible debt). Therefore it falls under Capital/Financing Update (CAP).
2026-04-01 Korean
최대주주변경
Major Shareholding Notification Classification · 1% confidence The document is a formal disclosure of a change in the company’s largest shareholder, showing pre‐ and post‐ownership percentages, dates, and reasons. This matches a Major Shareholding Notification, where ownership crosses thresholds and a new major shareholder emerges.
2026-03-31 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a voluntary public disclosure (자율공시) announcing the results of a paid-in capital increase via third-party allotment, detailing the number of shares issued, issuance amounts, board resolution dates, payment date, and changes to major shareholders. This fits the "Share Issue/Capital Change" category.
2026-03-31 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.